Plain-English translation of NCT06001502 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether virtual reality distraction therapy can help patients manage pain and anxiety during the first few days after coronary artery bypass grafting (CABG), a common heart surgery. Half of the 100 patients will use a virtual reality device on days 1, 2, and 3 after surgery, while the other half will receive the standard pain and anxiety treatments. Researchers want to see if this new treatment can help patients feel better and recover more comfortably.
After heart surgery, patients often experience significant pain and anxiety during recovery, which can slow healing and affect quality of life. This trial is exploring whether virtual reality—a tool that immerses patients in a calming digital environment—could be a helpful addition to standard pain management to improve patients' recovery experience.
If you join this study, you will have heart bypass surgery as planned. After surgery, if you're assigned to the virtual reality group, you'll use a VR device for sessions on days 1, 2, and 3 while recovering on the hospital ward. If you're in the standard care group, you'll receive regular pain and anxiety management. Either way, you'll complete short questionnaires about your pain, anxiety, and recovery during your hospital stay and again 6 weeks after surgery.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Netherlands